Finch Therapeutics | 8-K: Current report
Apr 3 19:32
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SMISEK JEFFERY A
Mar 30 04:19
Finch Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 29 04:41
Finch Therapeutics | 10-K: Annual report
Mar 26 04:36
Finch Therapeutics | 8-K: Current report
Feb 24 05:16
Finch Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Chidozie Ugwumba(9.99%)
Dec 14, 2023 06:20
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SMISEK JEFFERY A
Nov 28, 2023 05:54
Finch Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Nov 23, 2023 05:37
Finch Therapeutics | 8-K: Current report
Nov 18, 2023 05:30
Finch Therapeutics: Q3 2023 Earnings Report
Nov 8, 2023 19:30
Finch Therapeutics | 10-Q/A: Quarterly report (Amendment)
Aug 11, 2023 18:31
Finch Therapeutics | 10-Q: Q2 2023 Earnings Report
Aug 10, 2023 18:31
Finch Therapeutics | 8-K: Current report
Jul 8, 2023 04:30
Finch Therapeutics | 8-K: Current report
Jun 29, 2023 04:31
Finch Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Executive Officer Blischak Matthew P.
Jun 24, 2023 04:30
Finch Therapeutics | 8-K: Current report
Jun 23, 2023 19:30
Finch Therapeutics | 8-K: Current report
Jun 10, 2023 05:00
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Blischak Matthew P.
Jun 10, 2023 04:52
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lange Christian H.
Jun 10, 2023 04:22
Finch Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SMISEK JEFFERY A
Jun 10, 2023 04:18
No Data
No Data